Stata DX

Stata DX is a developer of a disease management eRapid technology designed to implement custom biomarker panels for clinical studies.

Stata DX is active in the health space based in Kyoto, Japan.

Profile

Stata DX is a developer of a disease management eRapid technology designed to implement custom biomarker panels for at-home patient monitoring in clinical studies. The company's technology is a low-cost, affinity-based electrochemical sensing platform that can simultaneously detect a wide range of biomarkers in complex biological fluids, specifically liquid MRI for the brain, with high sensitivity and selectivity using as little as a single drop of blood, allowing researchers to learn about the composition of a system in real-time. Stata DX was established in Cambridge, Massachusetts.

Within the health space, the company focuses on its core offering rather than a broad product line.

The company is recorded as being based in Kyoto, Japan.

Directory data places it at the Plug and Play portfolio startup stage.

Website: statadx.com